GlassScriptPhysician profile
Anubhav Amin
NPI 1659773117
$30,385.83
in general payments reported to CMS, 2019-2025
11 companies · $8,546 in 2025
The $8,546 reported for 2025 was more than what 84% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $30.10 · 2021: $15K · 2022: $1,533 · 2023: $2,394 · 2024: $3,035 · 2025: $8,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,500 · Travel and Lodging: $5,173 · Food and Beverage: $1,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,500.00 |
| Travel and Lodging | $5,172.62 |
| Food and Beverage | $1,302.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $14,527.56 | 2021-2025 | Alif, Xlif, Excelsiusgps Robotic Navigation System |
| Icotec Medical INC. | $13,105.56 | 2021-2022 | |
| Medtronic, INC. | $1,333.89 | 2021-2025 | Stealthstation S8 Platform |
| Alphatec Spine, INC | $592.62 | 2024-2025 | Other - Miscellaneous |
| Providence Medical Technology, INC. | $243.09 | 2023 | |
| Depuy Synthes Sales INC. | $188.94 | 2021-2025 | |
| Medtronic USA, INC. | $140.37 | 2019 | |
| Kuros Biosciences USA, INC | $124.09 | 2022-2023 | |
| Carbofix Spine INC | $62.17 | 2025 | |
| Cerapedics INC. | $37.44 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Boston Scientific Corporation | $30.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anubhav Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.